GlassScriptPhysician profile
Anthony Lee Rosa
NPI 1245294941
$11,494.57
in general payments reported to CMS, 2019-2025
32 companies · $2,819 in 2025
The $2,819 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $419 · 2021: $439 · 2022: $1,488 · 2023: $1,872 · 2024: $2,782 · 2025: $2,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,439 · Education: $33.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,439.45 |
| Education | $33.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,035.31 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,833.18 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Janssen Biotech, INC. | $1,174.22 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $1,157.47 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Gilead Sciences, INC. | $573.16 | 2019-2025 | |
| Pfizer INC. | $499.82 | 2019-2025 | |
| Celgene Corporation | $470.63 | 2022-2024 | Zeposia |
| Madrigal Pharmaceuticals | $273.50 | 2024-2025 | Rezdiffra, Resmetirom |
| Ardelyx, INC. | $259.47 | 2023-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $256.56 | 2022-2025 | Dupixent |
| Intercept Pharmaceuticals, INC. | $255.60 | 2019-2025 | Ocaliva |
| Qol Medical, LLC | $246.38 | 2021-2025 | Sucraid, Sucraid |
| Braintree Laboratories, INC. | $229.12 | 2019-2025 | Suflave, Sutab |
| Merck Sharp & Dohme LLC | $203.04 | 2019-2024 | Dificid |
| Lilly USA, LLC | $172.99 | 2023-2025 | Omvoh |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $128.12 | 2022-2025 | |
| Ucb, INC. | $123.57 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $109.62 | 2024-2025 | Iqirvo |
| Ironwood Pharmaceuticals, INC | $98.63 | 2019-2025 | |
| Redhill Biopharma INC. | $72.27 | 2021-2022 | |
| Celltrion USA INC. | $52.57 | 2023-2025 | Vegzelma, Zymfentra, Yuflyma |
| Aimmune Therapeutics, INC. | $41.77 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $32.08 | 2025 | Voquezna |
| Ferring Pharmaceuticals INC. | $29.66 | 2019-2022 | |
| Evoke Pharma, INC. | $29.39 | 2023-2025 | Gimoti |
| Concordia Pharmaceuticals INC. | $27.72 | 2019 | |
| Intra-Sana Laboratories | $24.21 | 2022 | |
| Allergan, INC. | $23.58 | 2019 | |
| Boston Scientific Corporation | $19.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2024 | Cyltezo |
| Shionogi INC | $13.84 | 2019 | |
| Alfasigma USA, INC. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.